Leading Companies Enhancing Their Roles in the Cell and Gene Therapy Supply Chain and Logistics Market

The cell and gene therapy supply chain and logistics sector is on the brink of substantial growth as personalized medical treatments continue to expand globally. Increasing demand for efficient and transparent supply chain operations is fueling advancements, while innovative technologies and infrastructure investments are reshaping how these therapies reach patients. Let's explore the market size, key drivers, leading companies, emerging trends, and segment dynamics shaping this evolving industry.

Anticipated Growth Trajectory of the Cell and Gene Therapy Supply Chain Logistics Market
The market size for cell and gene therapy supply chain and logistics is projected to grow swiftly, reaching $2.81 billion by 2030 with a compound annual growth rate (CAGR) of 12.1%. This rapid expansion is driven by various factors including the increasing commercialization of personalized therapies and the rising need for end-to-end visibility throughout the supply chain. Additionally, the growth of global therapy distribution networks, growing adoption of cloud-based logistics platforms, and enhanced investments in smart cold chain infrastructure contribute significantly to market development. Key trends expected to fuel this growth are the expansion of integrated cold chain management systems, the widespread use of real-time tracking and traceability technologies, rising reliance on cryogenic logistics, increasing patient-centered supply chain models, and a stronger emphasis on chain of custody compliance.

Download a free sample of the cell and gene therapy supply chain/logistics market report:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Factors Promoting Market Expansion: Demand for Personalized Therapies
One of the primary factors accelerating the expansion of the cell and gene therapy supply chain market is the growing commercialization and adoption of personalized medical therapies. As these treatments become more common, the need for highly specialized, integrated logistics solutions that can manage complex handling requirements also rises. This trend is prompting stakeholders to seek comprehensive supply chain visibility and more robust tracking mechanisms to ensure safety and efficacy throughout the therapy journey.

Investments and Technology Adoption Supporting Market Growth
Alongside increasing therapy demand, significant investments in technology and infrastructure are playing a critical role. The expansion of cloud-based logistics platforms offers enhanced operational efficiency and facilitates real-time data sharing. Meanwhile, the development of smart cold chain infrastructure ensures temperature-sensitive therapies are maintained within strict parameters. These advancements enable a more reliable and scalable supply chain network, well-suited for the highly specialized needs of cell and gene therapies.

The cell and gene therapy supply chain and logistics sector is on the brink of substantial growth as personalized medical treatments continue to expand globally. Increasing demand for efficient and transparent supply chain operations is fueling advancements, while innovative technologies and infrastructure investments are reshaping how these therapies reach patients. Let's explore the market size, key drivers, leading companies, emerging trends, and segment dynamics shaping this evolving industry.

Anticipated Growth Trajectory of the Cell and Gene Therapy Supply Chain Logistics Market
The market size for cell and gene therapy supply chain and logistics is projected to grow swiftly, reaching $2.81 billion by 2030 with a compound annual growth rate (CAGR) of 12.1%. This rapid expansion is driven by various factors including the increasing commercialization of personalized therapies and the rising need for end-to-end visibility throughout the supply chain. Additionally, the growth of global therapy distribution networks, growing adoption of cloud-based logistics platforms, and enhanced investments in smart cold chain infrastructure contribute significantly to market development. Key trends expected to fuel this growth are the expansion of integrated cold chain management systems, the widespread use of real-time tracking and traceability technologies, rising reliance on cryogenic logistics, increasing patient-centered supply chain models, and a stronger emphasis on chain of custody compliance.

Download a free sample of the cell and gene therapy supply chain/logistics market report:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR
Factors Promoting Market Expansion: Demand for Personalized Therapies
One of the primary factors accelerating the expansion of the cell and gene therapy supply chain market is the growing commercialization and adoption of personalized medical therapies. As these treatments become more common, the need for highly specialized, integrated logistics solutions that can manage complex handling requirements also rises. This trend is prompting stakeholders to seek comprehensive supply chain visibility and more robust tracking mechanisms to ensure safety and efficacy throughout the therapy journey.

Investments and Technology Adoption Supporting Market Growth
Alongside increasing therapy demand, significant investments in technology and infrastructure are playing a critical role. The expansion of cloud-based logistics platforms offers enhanced operational efficiency and facilitates real-time data sharing. Meanwhile, the development of smart cold chain infrastructure ensures temperature-sensitive therapies are maintained within strict parameters. These advancements enable a more reliable and scalable supply chain network, well-suited for the highly specialized needs of cell and gene therapies.

Major Players Driving the Cell and Gene Therapy Supply Chain Market
The market features several leading companies that have established strong positions in this space. Prominent names include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel Limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., and Biostor Ltd.

Noteworthy Acquisition Strengthening Cold Chain Services
In October 2025, US-based Peli BioThermal, a specialist in temperature-controlled packaging solutions, acquired EVO, a US cold chain logistics company focused on cell and gene therapy supply chains, for an undisclosed sum. This strategic move aims to broaden Peli BioThermal's cold chain capabilities, enhance services for temperature-sensitive shipments, and extend its global logistics network. The acquisition is expected to bolster Peli BioThermal's position in the life sciences and healthcare sectors by supporting the growing demand for specialized cold chain solutions.

Key Emerging Trends Shaping the Cell and Gene Therapy Supply Chain
Leading companies within the cell and gene therapy logistics market are innovating to meet expanding customer needs. One important trend is the development and integration of growth factor-rich biomaterials that enhance tissue regeneration and wound healing. Such advancements improve patient outcomes and open new avenues for biomaterial applications in therapy supply chains.

For example, in October 2023, ZimVie, a US-based medical device manufacturer, introduced the Biotivity A/C Plus Membrane, a novel growth factor-rich membrane. Derived from human placental tissue, this biomaterial promotes optimal wound healing during jaw repair and dental implant reconstruction. It is unique due to its minimal manipulation and antibiotic-free sterilization using the Excellion Process, distinguishing it from other membranes on the market.

Breakdown of Critical Segments in the Cell and Gene Therapy Supply Chain Market
This market is segmented into multiple categories:

1) Software Solutions: Including cell orchestration platforms, enterprise manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems.

2) Deployment Modes: Cloud-based solutions and on-premises solutions.

3) Components: Such as cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipments, storage mediums, cryogenic packout kits, and other related components.

4) Application Areas: Covering donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up.

5) End Users: Encompassing biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

Subcategories cover specific functions within software solutions like workflow management and scheduling in cell orchestration platforms, production planning in enterprise manufacturing systems, stock tracking in inventory management, sample tracking in laboratory information management systems, route optimization in logistics systems, patient scheduling in patient management systems, compliance tracking in quality management, and real-time shipment tracking in tracking and tracing systems.

Regional Overview and Growth Patterns
As of 2024, North America holds the largest share of the cell and gene therapy supply chain and logistics market. However, the Asia-Pacific region is expected to experience the fastest growth rate in the coming years. The market outlook encompasses significant regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa, providing a thorough understanding of global growth dynamics and opportunities.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.